ATE442456T1 - Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs - Google Patents

Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs

Info

Publication number
ATE442456T1
ATE442456T1 AT03785912T AT03785912T ATE442456T1 AT E442456 T1 ATE442456 T1 AT E442456T1 AT 03785912 T AT03785912 T AT 03785912T AT 03785912 T AT03785912 T AT 03785912T AT E442456 T1 ATE442456 T1 AT E442456T1
Authority
AT
Austria
Prior art keywords
dna
plasma
circulative
determining
cancer
Prior art date
Application number
AT03785912T
Other languages
English (en)
Inventor
Gabriella Sozzi
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Application granted granted Critical
Publication of ATE442456T1 publication Critical patent/ATE442456T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6818Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03785912T 2002-12-23 2003-12-22 Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs ATE442456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002743A ITMI20022743A1 (it) 2002-12-23 2002-12-23 Metodo per la determinazione del rischio di comparsa, della presenza o del decorso di malattie tumorali.
PCT/EP2003/014719 WO2004057024A1 (en) 2002-12-23 2003-12-22 Method for the detection of cancer

Publications (1)

Publication Number Publication Date
ATE442456T1 true ATE442456T1 (de) 2009-09-15

Family

ID=32676859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03785912T ATE442456T1 (de) 2002-12-23 2003-12-22 Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs

Country Status (9)

Country Link
US (1) US7888008B2 (de)
EP (1) EP1576187B1 (de)
AT (1) ATE442456T1 (de)
AU (1) AU2003294932A1 (de)
DE (1) DE60329224D1 (de)
DK (1) DK1576187T3 (de)
ES (1) ES2332716T3 (de)
IT (1) ITMI20022743A1 (de)
WO (1) WO2004057024A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406463T1 (de) * 2005-04-06 2008-09-15 Maurice Stroun Methode zur krebsdiagnose mittels nachweis von dna und rna im kreislauf
CN104593505A (zh) * 2015-01-23 2015-05-06 上海迪安医学检验所有限公司 一种检测全血或血清样品中端粒酶的活性程度的试剂盒
JP7239973B2 (ja) * 2017-12-19 2023-03-15 国立大学法人山口大学 前癌病変又は癌の有無の予測を補助する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034015A1 (en) * 1996-03-15 1997-09-18 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
CA2321259A1 (en) 1998-02-16 1999-08-19 University Of Maryland, Baltimore Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis
US7160996B1 (en) * 1999-06-09 2007-01-09 Bioresearch Technologies, Inc. Fluorescence energy transfer probes with stabilized conformations
US6664046B1 (en) * 1999-12-16 2003-12-16 Roche Molecular Systems, Inc. Quantitation of hTERT mRNA expression
EP1158055A1 (de) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Verfahren zur Diagnose von Krebs

Also Published As

Publication number Publication date
DE60329224D1 (de) 2009-10-22
AU2003294932A1 (en) 2004-07-14
ES2332716T3 (es) 2010-02-11
US20070148644A1 (en) 2007-06-28
WO2004057024A1 (en) 2004-07-08
EP1576187A1 (de) 2005-09-21
US7888008B2 (en) 2011-02-15
ITMI20022743A1 (it) 2004-06-24
EP1576187B1 (de) 2009-09-09
DK1576187T3 (da) 2010-01-11

Similar Documents

Publication Publication Date Title
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
ATE508202T1 (de) Verfahren zur diagnose von brustkrebs
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
EP2386860A3 (de) Vorhersage von Letalität und Detektion von schweren Erkrankungen
WO2004055519A3 (en) Specific markers for pancreatic cancer
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
WO2004112570A3 (en) Detection of survivin in the biological fluids of cancer patients
WO2005078624A3 (en) A method of recruiting patients for a clinical study
WO2005121362A3 (en) Method for selectively quantifying vegf isoforms in a biological sample and uses thereof.
DK2038430T3 (da) Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
WO2004113574A3 (en) Methods for disease screening
RU2012133434A (ru) Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения
WO2008018789A3 (en) Methods and means for diagnosing and treatment of osteoarthritis
ATE515576T1 (de) Protein c polymorphismen
WO2004057343A3 (en) Detection or determination of variants of factor xiia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties